(Q33688395)

28 July 2017

1 reference

title

Population newborn screening for inherited metabolic disease: current UK perspectives (English)

1 reference

28 July 2017

1 reference

A Green

1

1 reference

PubMed ID

10407789

28 July 2017

R J Pollitt

series ordinal

2

1 reference

28 July 2017

1 June 1999

1 reference

Journal of Inherited Metabolic Disease

28 July 2017

1 reference

28 July 2017

22

1 reference

28 July 2017

4

1 reference

28 July 2017

572-579

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1005572710844

28 July 2017

0 references

cites work

Clinical trials and rare diseases: a way out of a conundrum

1 reference

12 December 2020

Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry

1 reference

12 December 2020

Rapid diagnosis of homocystinuria and other hypermethioninemias from newborns' blood spots by tandem mass spectrometry

1 reference

12 December 2020

Neonatal screening for inborn errors of metabolism: cost, yield and outcome.

1 reference

12 December 2020

New developments in neonatal screening

1 reference

12 December 2020

Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening

1 reference

12 December 2020

Nutritional benefits of neonatal screening for cystic fibrosis. Wisconsin Cystic Fibrosis Neonatal Screening Study Group

1 reference

12 December 2020

Newborn screening for inborn errors of metabolism: a systematic review.

1 reference

12 December 2020

Evaluating newborn screening programmes based on dried blood spots: future challenges

1 reference

12 December 2020

Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry

1 reference

12 December 2020

Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry.

1 reference

12 December 2020

Neonatal screening for cystic fibrosis. Cystic fibrosis should be added to diseases sought in all newborn babies

1 reference

12 December 2020

Why "underpowered" trials are not necessarily unethical

1 reference

12 December 2020

Tandem mass spectrometry--the potential

1 reference

12 December 2020

Incidence of congenital hypothyroidism: retrospective study of neonatal laboratory screening versus clinical symptoms as indicators leading to diagnosis

1 reference

12 December 2020

The ethics of randomised controlled trials from the perspectives of patients, the public, and healthcare professionals

1 reference

12 December 2020

Neonatal screening for cystic fibrosis

1 reference

12 December 2020

Regional variations in medium-chain acyl-CoA dehydrogenase deficiency

1 reference

12 December 2020

1 reference

12 December 2020

Equipoise and the ethics of randomization.

1 reference

12 December 2020

Delay in diagnosis of homocystinuria: retrospective study of consecutive patients

1 reference

Crossref

https://api.crossref.org/works/10.1023%2FA%3A1005572710844

7 January 2021

inferred from DOI database lookup

Neonatal screening for cystic fibrosis. Early diagnosis is important to parents even if it makes little difference to outcome

1 reference

Crossref

https://api.crossref.org/works/10.1023%2FA%3A1005572710844

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1023/A:1005572710844

1 reference

PubMed ID

10407789

Dimensions Publication ID

28 July 2017

0 references

1 reference

PubMed ID

10407789